1. Home
  2. KPTI vs GIFI Comparison

KPTI vs GIFI Comparison

Compare KPTI & GIFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KPTI
  • GIFI
  • Stock Information
  • Founded
  • KPTI 2008
  • GIFI 1985
  • Country
  • KPTI United States
  • GIFI United States
  • Employees
  • KPTI N/A
  • GIFI N/A
  • Industry
  • KPTI Biotechnology: Pharmaceutical Preparations
  • GIFI Metal Fabrications
  • Sector
  • KPTI Health Care
  • GIFI Industrials
  • Exchange
  • KPTI Nasdaq
  • GIFI Nasdaq
  • Market Cap
  • KPTI 102.4M
  • GIFI 116.3M
  • IPO Year
  • KPTI 2013
  • GIFI 1997
  • Fundamental
  • Price
  • KPTI $6.29
  • GIFI $7.99
  • Analyst Decision
  • KPTI Strong Buy
  • GIFI
  • Analyst Count
  • KPTI 7
  • GIFI 0
  • Target Price
  • KPTI $31.71
  • GIFI N/A
  • AVG Volume (30 Days)
  • KPTI 302.2K
  • GIFI 47.8K
  • Earning Date
  • KPTI 11-11-2025
  • GIFI 11-04-2025
  • Dividend Yield
  • KPTI N/A
  • GIFI N/A
  • EPS Growth
  • KPTI N/A
  • GIFI N/A
  • EPS
  • KPTI N/A
  • GIFI 0.60
  • Revenue
  • KPTI $137,269,000.00
  • GIFI $152,867,000.00
  • Revenue This Year
  • KPTI $3.40
  • GIFI N/A
  • Revenue Next Year
  • KPTI $9.69
  • GIFI N/A
  • P/E Ratio
  • KPTI N/A
  • GIFI $13.32
  • Revenue Growth
  • KPTI N/A
  • GIFI 14.32
  • 52 Week Low
  • KPTI $3.51
  • GIFI $5.12
  • 52 Week High
  • KPTI $16.95
  • GIFI $8.23
  • Technical
  • Relative Strength Index (RSI)
  • KPTI 53.09
  • GIFI 68.23
  • Support Level
  • KPTI $5.71
  • GIFI $7.34
  • Resistance Level
  • KPTI $6.75
  • GIFI $7.50
  • Average True Range (ATR)
  • KPTI 0.58
  • GIFI 0.26
  • MACD
  • KPTI 0.03
  • GIFI 0.04
  • Stochastic Oscillator
  • KPTI 81.25
  • GIFI 75.69

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.

About GIFI Gulf Island Fabrication Inc.

Gulf Island Fabrication Inc is a U.S. based company that is a fabricator of complex steel structures and marine vessels. The company also provides installation, hook-up, commissioning, repair, and maintenance services with specialized crews. The company operates through segments namely Fabrication division which fabricates structures such as offshore drilling and production platforms and other steel structures for customers in the oil and gas industries; the Shipyards division manufactures newly built and repairs various steel marine vessels in the United States; the Services division provides interconnect piping services on offshore platforms, welding, and inshore structures and also provides maintenance and industrial facilities. Majority revenue is from services segment.

Share on Social Networks: